Ramucirumab 認識化療藥品Ramucirumab
2025/3/28
Ramucirumab is a monoclonal antibody that binds to VEGF receptor-2 (VEGFR2) and blocks the binding of VEGF-A, VEGF-C and VGEF-D. By blocking the activation of VEGFR2, ramucirumab inhibits the development of new blood vessels and helps cut off the blood supply, thereby reducing oxygen and nutrients to the tumor. This may interfere with cancer cell growth.